Chronic effects of .BETA.1-adrenoceptor partial agonist xamoterol on resting and exercise hemodynamics in patients with heart failure.
Hideyuki Sato(University of Shizuoka), Takenobu Kamada(The University of Osaka), Masao Yasuno(Osaka Rosai Hospital), Takao Maeda(Mie University), N Ohgidani, Noritake Hoki, Tatsuhiko Ohara, Yoshio Yamada(Osaka Rosai Hospital), Hitoshi Ozaki(Saba University School of Medicine), Toshio Katô(Osaka Hospital), Masakatsu Fukushima(Osaka National Hospital), T Matsuyama(Saba University School of Medicine), S Ohnishi(Osaka National Hospital), Michitoshi Inoue(Osaka University Hospital), Fuminobu Ishikura(National Cerebral and Cardiovascular Center), Akira Kitabatake(Hokkaido University), Masatake Fukunami(Osaka Prefectural Institute of Public Health)
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
January 1, 1988
Cited by 0
Related Papers
‘Ischemic tolerance’ phenomenon found in the brain
|Brain Research|1990|1.1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Development of Defective and Persistent Sendai Virus Vector
|Journal of Biological Chemistry|2010|373
Chronic Estrogen Supplementation Following Ovariectomy Improves the Emotional Stress-Induced Cardiovascular Responses by Indirect Action on the Nervous System and by Direct Action on the Heart
|Circulation Journal|2007|185
Can Exercise Training With Weight Loss Lower Serum C-Reactive Protein Levels?
|Arteriosclerosis Thrombosis and Vascular Biology|2004|171